Among all the firms announcing their interest in working towards designing and producing a preventive vaccine for COVID-19 only Moderna (MRNA) has accomplished that job and delivered it to the health authorities to decide upon the next step.
Moderna’s stock soared. The stock did not go up in expectation of the millions . . .